Diabetic nephropathy: renal development gone awry?

被引:19
作者
Dolan, V
Hensey, C
Brady, HR [1 ]
机构
[1] Univ Coll Dublin, Mater Misericordiae Hosp, Conway Inst Biomol & Biomed Res, Dept Med & Therapeut, Dublin 2, Ireland
[2] Dublin Mol Med Ctr, Dublin, Ireland
[3] Univ Coll Dublin, Mater Misericordiae Hosp, Conway Inst Biomol & Biomed Res, Dept Pharmacol, Dublin 2, Ireland
[4] Dept Med & Therapeut, Dublin 7, Ireland
关键词
diabetic nephropathy; glomerulosclerosis; gene expression; gremlin; transforming growth factor-beta; connective tissue growth factor;
D O I
10.1007/s00467-002-0988-x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Nephrogenesis is controlled by a sequence of inductive signals between different areas of the developing kidney. As these signals are being elucidated, it has become clear that many important developmental genes are re-expressed in the mature organ following injury, possibly as part of repair and regeneration. While this reuse of developmental pathways may contribute to healing and repair, it may alternatively result in scar formation if specific components of the pathways are missing, if the temporal correlation of various elements is faulty, or if an injurious stimulus persists. In the review we will use diabetic nephropathy as an example to illustrate this paradigm in renal disease. The pathogenesis of diabetic nephropathy is complex and characterized by altered expression of many genes, including growth factors, apoptotic regulators, cellular matrix components, and cytoskeletal proteins. Many of these factors also function during kidney development. The elucidation of the roles these genes play in nephrogenesis and of their array of molecular partners and modulators may ultimately shed light on the pathogenesis of disease (and indeed vice versa), and may even suggest new therapeutic strategies.
引用
收藏
页码:75 / 84
页数:10
相关论文
共 71 条
[1]  
Bernardini N, 1996, DEV DYNAM, V206, P231, DOI 10.1002/(SICI)1097-0177(199607)206:3<231::AID-AJA1>3.0.CO
[2]  
2-J
[3]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[4]   Role of vascular endothelial growth factor in diabetic nephropathy [J].
Cha, DR ;
Kim, NH ;
Yoon, JW ;
Jo, SK ;
Cho, WC ;
Kim, HK ;
Won, NH .
KIDNEY INTERNATIONAL, 2000, 58 :S104-S112
[5]  
CHRIST M, 1994, J IMMUNOL, V153, P1936
[6]   Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes [J].
Cooper, ME ;
Vranes, D ;
Youssef, S ;
Stacker, SA ;
Cox, AJ ;
Rizkalla, B ;
Casley, DJ ;
Bach, LA ;
Kelly, DJ ;
Gilbert, RE .
DIABETES, 1999, 48 (11) :2229-2239
[7]   Protein kinase C in diabetic nephropathy [J].
Craven, PA ;
Studer, RK ;
Negrete, H ;
DeRubertis, FR .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 1995, 9 (04) :241-245
[8]   EPIDERMAL GROWTH-FACTOR RECEPTOR ACTIVATION IN DEVELOPING RAT-KIDNEY [J].
CYBULSKY, AV ;
GOODYER, PR ;
MCTAVISH, AJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (03) :F428-F436
[9]  
De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993
[10]   A REQUIREMENT FOR BONE MORPHOGENETIC PROTEIN-7 DURING DEVELOPMENT OF THE MAMMALIAN KIDNEY AND EYE [J].
DUDLEY, AT ;
LYONS, KM ;
ROBERTSON, EJ .
GENES & DEVELOPMENT, 1995, 9 (22) :2795-2807